The Ranks of Corporate Zombies Are Growing: Credit Weekly

The number of U.S. "zombie companies," defined as those unable to cover their interest expenses, has reached its highest level since early 2022, with nearly 100 added in October. This increase is primarily due to companies that accumulated debt at near-zero interest rates during the pandemic now facing elevated funding costs and tariffs. The trend signals growing financial stress within a segment of the corporate sector amid a rising interest rate environment.

Analysis

The number of U.S. "zombie companies," defined as those unable to cover their interest expenses, has reached its highest level since early 2022. Nearly 100 additional companies gained this designation in October alone, signaling a significant increase in corporate financial distress. This trend highlights a growing vulnerability within the corporate credit landscape.

This resurgence is primarily attributed to companies that leveraged cheap debt during the pandemic's near-zero interest rate environment. These firms are now facing substantial headwinds from elevated funding costs due to rising interest rates and the impact of tariffs. The shift in monetary policy has fundamentally altered the cost of capital for these highly indebted entities.

The strongly negative sentiment and pessimistic tone associated with this development suggest a potential for broader market impact, particularly within the credit and bond markets. The increasing prevalence of zombie companies indicates deteriorating company fundamentals for a segment of the economy, which could lead to increased defaults and credit downgrades, affecting investor confidence and capital allocation.

Key Decisions for Investors

• Investors should conduct thorough due diligence on corporate credit exposures, particularly for companies with high debt loads acquired during low-interest rate periods.
• Monitor sectors heavily impacted by tariffs and those with a high proportion of interest-rate-sensitive businesses for potential credit deterioration.
• Consider rebalancing portfolios to reduce exposure to highly leveraged companies that may struggle with sustained higher interest rates, favoring firms with robust cash flows and stronger balance sheets.